Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

900 recalls · Class II, newest first

Class II · Moderate risk

Lisdexamfetamine Dimesylate Capsules

Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.

Terminated Labeling / mix-up Lannett Company Inc. NDC 0527-4664-37 D-0599-2025
Class II · Moderate risk

Phenazopyridine HCl

Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.

Terminated Labeling / mix-up RemedyRepack Inc. D-0549-2024
Class II · Moderate risk

Petroleum Jelly

Labeling: Label Mix up; product labeled as pure white petroleum jelly actually contains petroleum jelly with Lavendar and Chamomile

Terminated Labeling / mix-up Consumer Product Partners, LLC D-0560-2024
Class II · Moderate risk

Bicillin L-A

cGMP Deviations: Products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 60793-0701-10 D-0373-2024
Class II · Moderate risk

Rocuronium Bromide Injection

cGMP Deviations: Products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 55150-226-10 D-0371-2024
Class II · Moderate risk

Digoxin Tablets

Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.

Terminated Labeling / mix-up Marlex Pharmaceuticals, Inc. NDC 10135-0748-01 D-1170-2023
Class II · Moderate risk

Capsaicin Cream 0.025%

Product mix-up: Cartons labeled Capsaicin Cream 0.025% may contain tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste

Terminated Labeling / mix-up Avkare LLC NDC 50268-195-60 D-1147-2023
Class II · Moderate risk

Sodium Fluoride 1.1%

Cases of Sodium Fluoride 1.1% Prescription Dental Toothpaste may contain cartons labeled as Capsaicin Cream 0.025% but contain correctly labeled tubes of Sodium Fluoride 1.1% Prescription Dental Toothpaste

Terminated Labeling / mix-up Avkare LLC NDC 42291-741-51 D-1146-2023
Class II · Moderate risk

hello wild strawberry fluoride toothpaste

Labeling: Label Mix-Up: Some hello wild strawberry fluoride toothpaste, packaged in cartons labeled as hello wild strawberry fluoride toothpaste were incorrectly filled in tubes labeled as hello fresh watermelon fluoride free toothpaste.

Terminated Labeling / mix-up Colgate Palmolive Company D-1084-2023
Class II · Moderate risk

Famotidine Tablets

Labeling: Label Error on Declared Strength: some cartons labeled and containing 20 mg may have an external label placed on the side of the carton indicating strength as 10 mg.

Terminated Labeling / mix-up Glenmark Therapeutics, Inc. NDC 72657-113-20 D-0939-2023
Class II · Moderate risk

Ganciclovir for Injection

Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.

Terminated Labeling / mix-up Hikma Pharmaceuticals USA Inc. NDC 0143-9299-01 D-0090-2023
Class II · Moderate risk

Dextroamphetamine Saccharate

Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.

Terminated Labeling / mix-up Teva Pharmaceuticals USA Inc NDC 0555-0777-02 D-1539-2022
Class II · Moderate risk

Alcohol Swabsticks

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 67777-300-01 D-1327-2022
Class II · Moderate risk

Sterile Alcohol Prep Pads

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 67777-121-16 D-1326-2022
Class II · Moderate risk

Racepinephrine Inhalation Solution

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0487-5901-99 D-1325-2022
Class II · Moderate risk

Dakin's Solution

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0436-0672-16 D-1323-2022
Class II · Moderate risk

A&D Original Ointment

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 11523-0096-3 D-1322-2022
Class II · Moderate risk

Pataday

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-8150-01 D-1321-2022
Class II · Moderate risk

GenTeal Tears

CGMP Deviations: products were stored outside the drug label specifications.

Terminated Labeling / mix-up Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-0518-01 D-1320-2022

Recalls by year